InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Roberts Eiry, Directeur Médical. Officer active across 3 companies, notably Amicus Therapeutics, INC.. In total, 24 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €3.8m. History available since 10 June 2021. The latest transaction was filed on 22 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Roberts Eiry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
45,871 shares0Common Shares, No Par ValueSEC:0000885590-26-000082:0
76,275 shares@ US$14.500.024% mcap100.0% of flowCommon StockSEC:0001193125-26-182275:0
20,414 shares0Common StockSEC:0000950170-25-083215:0
2,113 shares0Common StockSEC:0000914475-25-000069:0
1,860 shares0Common StockSEC:0000914475-25-000051:0
2,769 shares0Common StockSEC:0000914475-25-000029:0
5,140 shares@ US$77.814.4% of flowCommon StockSEC:0000914475-24-000220:0
11,847 shares0Common StockSEC:0000950170-24-071007:0
1,114 shares@ US$132.96391.6% of flowCommon StockSEC:0000914475-24-000076:0
1,121 shares@ US$142.23561.8% of flowCommon StockSEC:0000914475-24-000049:0
1,457 shares@ US$140.79062.2% of flowCommon StockSEC:0000914475-24-000031:0
10,000 shares@ US$126.744813.7% of flowCommon StockSEC:0001209191-23-059774:0
6,978 shares@ US$81.056.2% of flowCommon StockSEC:0001209191-23-058683:0
38,722 shares@ US$77.8133.2% of flowCommon StockSEC:0001209191-23-058116:0
8,396 shares@ US$77.817.2% of flowCommon StockSEC:0001209191-23-057986:0
3,198 shares@ US$107.37583.7% of flowCommon StockSEC:0001209191-23-047140:0
8,584 shares0Common StockSEC:0001209191-23-036422:0
14,400 shares@ US$103.476316.0% of flowCommon StockSEC:0001209191-23-025763:0
1,121 shares@ US$105.80041.3% of flowCommon StockSEC:0001209191-23-007916:0
1,457 shares@ US$109.98871.8% of flowCommon StockSEC:0001209191-23-006282:0
12,671 shares0Common StockSEC:0001209191-22-035847:0
1,623 shares@ US$80.76761.4% of flowCommon StockSEC:0001209191-22-008216:0
2,632 shares@ US$74.50142.1% of flowCommon StockSEC:0001209191-22-003104:0
22,759 shares0Common StockSEC:0001209191-21-040374:0
24 of 24 declarations
About Roberts Eiry
ROBERTS EIRY is Chief Medical Officer. He has 24 filings in total, and in the recent filings we hold, the transactions are sales for a total of EUR 4777220, over the period from 2021-06-14 to 2026-05-26. The main filings concern Neurocrine Biosciences INC, Amicus Therapeutics, INC., and Bausch Health Companies Inc.
